Oruka Therapeutics, Inc.
ORKA
$73.87-3.66%
End of day · as of Oct 16, 2026, 2:01 AM ET
Mkt cap
$4.27B
EV/Sales
N/A
P/E ratio
N/A
FY2023 Revenue
N/A
EPS (FY2023)
$-0.37
Gross Margin (FY2023)
N/A
Profit Margin (FY2023)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Latest reported ORKA revenue for 2023-12-31 was $0. Net income was -$5.3M. ORKA currently screens at market cap $4.27B.
Use this ORKA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ORKA income, balance, and cash tables.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company in the Healthcare sector.
Latest cached Oruka Therapeutics, Inc. (ORKA) net income for Dec 31, 2023 was -$5.3M. Statements: https://lician.com/financials/orka
Oruka Therapeutics, Inc. (ORKA) market capitalization is $4.27B on the latest cached snapshot.
Oruka Therapeutics, Inc. (ORKA) cached previous close $76.68; day range $73.81 – $76.00; volume 1,031,136. Session quote: https://lician.com/quote/orka
Oruka Therapeutics, Inc. (ORKA) latest cached earnings event is "ORKA earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ORKA filing is 8-K · Aug 24, 2026. Filings: https://lician.com/sec/orka